You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 13, 2025

Details for Patent: 4,387,089


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,387,089
Title: 4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethane
Abstract:The novel 4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethane is useful as a sunscreen agent. It exhibits outstanding UV-A absorbing qualities in that it brings about a considerable retardation in the ageing of the skin with excellent skin tolerance and stability (light, heat and moisture). 4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethane furthermore improves the protective action of UV B-filters, i.e. of substances which absorb the erythema-producing UV B-radiation in the range of about 290 to 320 mm.
Inventor(s): De Polo; Karl-Fred (Onex, CH)
Assignee: Givaudan Corporation (Clifton, NJ)
Application Number:06/264,774
Patent Claim Types:
see list of patent claims
Compound; Composition; Process; Use; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 4,387,089

Introduction

United States Patent 4,387,089, titled "4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethane," is a patent that describes a novel chemical compound useful as a sunscreen agent. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Invention Description

The patent, issued on June 7, 1983, describes a new chemical compound, 4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethane, which exhibits outstanding UV-A absorbing qualities. This compound is particularly useful as a sunscreen agent due to its ability to protect skin from ultraviolet radiation[5].

Claims

The patent includes several claims that define the scope of the invention. Here are the key claims:

  • Claim 1: The compound 4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethane.
  • Claim 2: A sunscreen composition containing the compound of claim 1.
  • Claim 3: A method of protecting skin from UV radiation using the compound of claim 1.

These claims are crucial as they define what is protected under the patent and what would constitute infringement.

Scope of the Invention

Chemical Structure and Properties

The patented compound is a specific dibenzoylmethane derivative with a dimethylethyl and methoxy group. Its unique structure contributes to its effectiveness as a UV-A absorber, making it a valuable component in sunscreen formulations[5].

Applications

The invention is primarily aimed at protecting skin from UV radiation, which is a critical aspect of skincare and sun protection. The compound can be used in various formulations, including creams, lotions, and sprays, to provide broad-spectrum sun protection.

Patent Landscape

Prior Art and Novelty

To understand the novelty of the invention, it is essential to look at the prior art in the field of sunscreen agents. The patent application would have been examined against existing patents and publications to ensure that the compound and its use were not previously disclosed. The issuance of the patent indicates that the compound and its specific use as a sunscreen agent were novel and non-obvious at the time of filing[5].

International Patent Filings

While the patent in question is a U.S. patent, it is common for inventors to file for patent protection in multiple countries. However, there is no indication in the provided sources that this specific patent was filed under the Patent Cooperation Treaty (PCT) or in other jurisdictions.

Related Patents and Technologies

Other patents in the field of sun protection and skincare often involve different chemical compounds or formulations. For example, patents like CA 1328409 describe photoprotective compositions using tocopherol sorbate, highlighting the diverse approaches to achieving sun protection[4].

Legal Status and Expiration

Current Status

The patent has expired, as indicated by its legal status. Patents typically have a lifetime of 20 years from the date of filing, after which the invention enters the public domain. This means that the compound and its use as described in the patent are no longer protected by patent law and can be freely used by anyone[5].

Implications of Expiration

The expiration of the patent allows other companies and individuals to manufacture and use the compound without needing to obtain a license from the original patent holder. This can lead to increased competition and potentially lower costs for consumers.

Search and Analysis Tools

USPTO Resources

For conducting a thorough analysis of patents like US 4,387,089, the United States Patent and Trademark Office (USPTO) provides several tools. The Patent Public Search tool, for instance, allows users to search for prior art and related patents. The Global Dossier and Common Citation Document (CCD) tools can also be useful in understanding the international patent family and citation data related to the patent[1].

International Databases

To see if similar patents exist in other countries, databases such as the European Patent Office's esp@cenet, the Japan Patent Office's database, and the World Intellectual Property Organization's PATENTSCOPE can be utilized[1].

Economic and Market Impact

Market Competition

The expiration of the patent can lead to increased market competition, as other companies can now produce and sell products containing the compound. This competition can drive innovation and reduce prices, benefiting consumers.

Innovation in Sun Protection

The availability of this compound in the public domain can also spur further innovation in sun protection technologies. Researchers and companies may build upon this invention to create even more effective sunscreen agents.

Key Takeaways

  • Compound Description: The patent describes a novel dibenzoylmethane derivative with UV-A absorbing properties.
  • Claims: The patent includes claims for the compound, sunscreen compositions, and methods of use.
  • Scope: The invention is primarily for protecting skin from UV radiation.
  • Legal Status: The patent has expired, allowing free use of the compound.
  • Market Impact: Expiration can lead to increased competition and innovation in sun protection.

FAQs

Q: What is the main use of the compound described in US Patent 4,387,089?

A: The compound is primarily used as a sunscreen agent to protect skin from UV radiation.

Q: Has the patent expired?

A: Yes, the patent has expired, which means the compound and its use are no longer protected by patent law.

Q: Can other companies now use the compound without a license?

A: Yes, since the patent has expired, other companies can freely use the compound without needing a license.

Q: How can one search for related patents?

A: Tools like the USPTO's Patent Public Search, Global Dossier, and international databases such as esp@cenet and PATENTSCOPE can be used to search for related patents.

Q: What are the potential market impacts of the patent's expiration?

A: The expiration can lead to increased competition, reduced prices, and further innovation in sun protection technologies.

Sources

  1. USPTO, "Search for patents - USPTO," https://www.uspto.gov/patents/search
  2. CAFC, "CONTOUR IP HOLDING LLC v. GOPRO, INC.," https://cafc.uscourts.gov/opinions-orders/22-1654.OPINION.9-9-2024_2381170.pdf
  3. USPTO, "Patent Claims Research Dataset - USPTO," https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Canadian Patents Database, "Patent 1328409 Summary," https://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/1328409/summary.html
  5. Google Patents, "US4387089A - 4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethane," https://patents.google.com/patent/US4387089A/en

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 4,387,089

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 4,387,089

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland11639/78Nov 13, 1978
Switzerland7686/79Aug 23, 1979

International Family Members for US Patent 4,387,089

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
France 2440933 ⤷  Try for Free
Germany 2945125 ⤷  Try for Free
Japan S5566535 ⤷  Try for Free
Switzerland 642536 ⤷  Try for Free
United Kingdom 2038807 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.